WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the 8 th annual LD Micro Main Event at the Luxe Sunset Bel Air Hotel in Los Angeles, CA on December 3, 2015 . Dr.

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,173,581. The patent covers the core technology deployed in the DPNCheck device. The claims cover the novel integrated design of the hand-held

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Canaccord Genuity Medical Technology and Diagnostics Forum at the Westin Grand Central , New York, NY on November

BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that it was granted the American Podiatric Medical Association (APMA) Seal of Approval for its Quell Wearable Pain Relief device. "The APMA Seal of Approval is awarded after a rigorous scientific review by a group of APMA

BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell will be one of 30 companies to present their latest innovations at CES Unveiled New York on November 10 . CES Unveiled is produced by the Consumer Electronics Association to provide a sneak peek at the year's most

BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) and Prism Health Care Services, Inc. , an affiliate of The Alden Network, today announced an agreement under which Prism will be the exclusive distributor of Quell ® wearable pain relief technology in Illinois and Wisconsin for patients in

Approximately 4,500 Quell ® Devices Shipped, Up 73% Compared to Q2 2015 DPNCheck ® Shipments at Three Year High of Nearly 40,000 Biosensors Revenue Up 44% to $2.1 Million Compared to Q3 2014 WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ: NURO) announced today that it plans to issue its 2015 third quarter financial results before the opening of the market on October 22, 2015 . The Company will host a conference call at 8:00 a.m., Eastern Time on October 22, 2015 to

BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell has been selected for the fifth annual Innovators Challenge that takes place during the Partners Healthcare's Connected Health Symposium on October 29 . The Innovators Challenge was established to showcase

BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Hammacher Schlemmer will feature Quell ® Wearable Pain Relief Technology in their upcoming catalog. "Hammacher Schlemmer has a 167-year history of offering the latest and most innovative products," said Frank McGillin ,